INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
NEW YORK CITY, NY / ACCESS Newswire / May 19, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM). Such investors are advised t...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
NEW YORK , May 12, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Humana" or the "Company") (NYSE: HUM). Such investors are advised to contact D...
HUM ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Humana Inc. investment
NEW YORK, NY / ACCESS Newswire / May 4, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Humana Inc. ("Humana Inc.") (NYSE:HUM) concerning possible violations of...
Humana's Q1 Earnings Beat Estimates on CenterWell Segment Strength
HUM's first-quarter results reflect higher primary care revenues and a well-performing Medicare stand-alone PDP business, partly offset by elevated operating costs.
Humana (HUM) Q1 Earnings Surpass Estimates
Humana (HUM) came out with quarterly earnings of $11.58 per share, beating the Zacks Consensus Estimate of $9.98 per share. This compares to earnings of $7.23 per share a year ago.
Humana beats first-quarter profit estimates on lower costs
Humana beat Wall Street estimates for first-quarter profit on Wednesday, as the health insurer spent less on medical services than expected.
Stay Ahead of the Game With Humana (HUM) Q1 Earnings: Wall Street's Insights on Key Metrics
Beyond analysts' top -and-bottom-line estimates for Humana (HUM), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarte...
Humana Board Declares Payment of Quarterly Dividend to Stockholders
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on July 25, 2025 to st...
Humana Gains Despite Medicare Advantage Losses—What's the Catch?
The medical sector giant was one of the first carriers to sound the alarm of rising inpatient utilization costs, notably with its Medicare Advantage (MA) plan members in Q4 2023.
Humana Q4 Earnings Review: A Tough Quarter -- And A Rating Downgrade
Humana Inc.'s Q4 and full-year 2024 earnings report shows a 10% revenue increase but significant losses, highlighting major structural issues in its business model. Rising healthcare utilization an...
Humana, Inc. (HUM) Q4 2024 Earnings Call Transcript
Humana, Inc. (NYSE:HUM ) Q4 2024 Earnings Conference Call February 11, 2025 9:00 AM ET Company Participants Lisa Stoner - VP, IR James Rechtin - President, CEO & Director Celeste Mellet - CFO Georg...
Humana (HUM) Reports Q4 Loss, Tops Revenue Estimates
Humana (HUM) came out with a quarterly loss of $2.16 per share versus the Zacks Consensus Estimate of a loss of $2.26. This compares to loss of $0.11 per share a year ago.
Humana Earnings On Deck: Investors Brace For Slower Growth Clip
Health insurance company Humana HUM is set to release its fourth-quarter 2024 earnings report on Feb. 11, before market hours. The stock has dropped 2.37% from the previous close, as of writing, on...
Will Lower Commercial Premiums Hurt Humana's Q4 Earnings?
HUM's Q4 results are likely to suffer a blow due to escalating operating costs, partly offset by membership growth in the Individual and Group Medicare Advantage business lines.
Countdown to Humana (HUM) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Besides Wall Street's top -and-bottom-line estimates for Humana (HUM), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the q...
Related Companies